Suven Pharmaceuticals reports 12% revenue growth for Q2 with strong outlook

Suven Pharmaceuticals reports 12% revenue growth for Q2 with strong outlook

Suven Pharmaceuticals Ltd. (BSE: 530239, NSE: SUVENPHARM), a technology-focused Contract Development and Manufacturing Organization (CDMO) headquartered in Hyderabad, announced a 12% year-over-year revenue growth for the second quarter of fiscal year 2025. Driven by a strengthened pipeline, increased customer requests, and key expansions, the company reported revenues of INR 258 crore, marking a steady path […]

CLSA sees major drop ahead for Ambuja Cements – Investors beware!

CLSA sees major drop ahead for Ambuja Cements – Investors beware!

CLSA, a global brokerage firm, has maintained an ‘Underperform’ rating for Ambuja Cements Limited, predicting a potential 9% decline in the stock’s value. CLSA’s target price of ₹570 reflects concerns over rising costs and intense competition, setting a cautious tone for investors looking at Ambuja Cements as a long-term bet. This bearish stance comes amidst […]